Ligamentolysis: What the Surgery Does, What It Doesn’t, and Why It Matters

Introduction: The Conversation Most Surgical Clinics Refuse to Have

Ligamentolysis is one of the most frequently searched male enhancement procedures on the internet. Yet the clinical reality of what it actually accomplishes, and what it permanently sacrifices, is almost never disclosed in full before a man walks into a consultation and signs a surgical consent form.

That silence is not accidental. The gap between what the peer-reviewed literature says about this surgery and what surgical clinic marketing says is not a minor discrepancy. It is a systematic omission that affects a man’s ability to give genuinely informed consent.

This article exists to close that gap. It walks through the biomechanical truth of what ligamentolysis does, what it permanently takes away, and what the satisfaction data actually shows when the numbers are read honestly. The men researching this procedure are intelligent, motivated, and often high-achieving professionals who deserve the same transparency a urologist would extend to a colleague, not a sanitized sales pitch.

The structure is deliberate: anatomy first, then surgical mechanics, then the outcomes data, then the post-operative burden, and finally the evidence-aligned alternatives. It is worth noting from the outset that this article is written by Stoller Medical Group, a practice that has deliberately chosen not to offer ligamentolysis. That decision is itself a clinical statement, and one worth explaining.

What the Suspensory Ligament Actually Does

The suspensory ligament is a fibrous band of connective tissue that anchors the base of the penile shaft to the pubic symphysis, the joint at the front of the pubic bone. In plain terms, it is the structure that holds the penis in position against the pelvis.

It performs three critical biomechanical functions. First, it stabilizes the erect penis during intercourse. Second, it maintains the upward or forward erection angle. Third, it helps protect the dorsal neurovascular bundle, the pathway of nerves and blood vessels responsible for sensation and erectile function, from repetitive mechanical trauma.

The Cleveland Clinic describes it concisely: the penile suspensory ligament “helps anchor your penis to your pelvis and supports sexual function.” That is a compact summary of exactly what is at stake when a surgeon cuts it.

Recent research complicates the old assumption that this ligament is a passive strap. A 2024 micro-anatomical investigation published in the Journal of Sexual Medicine, using epoxy sheet plastination and confocal microscopy, found that the ligament’s fibrous orientation is dynamic, functioning in a manner comparable to the cruciate ligaments of the knee. It is an active stabilizing structure, not a vestigial anchor.

The key message is straightforward: this ligament carries load, provides protection, and controls position during every erection. Understanding that is essential before evaluating what its removal costs.

What Ligamentolysis Actually Does, and Does Not Do

Ligamentolysis, also called suspensory ligament release or division, is a surgical procedure that cuts or releases the suspensory ligament. This allows the internal portion of the penile shaft, which is normally tucked against the pubic bone, to slide forward and outward.

Here is the distinction that most marketing content omits entirely: the procedure produces apparent flaccid lengthening, not anatomical growth. The corpora cavernosa, the erectile tissue cylinders that determine true penile size, are not altered. No new tissue is created. The penis simply hangs further out.

The flaccid gain averages approximately 26.38 mm (roughly one inch), but with an enormous individual range of 4 to 60 mm depending on anatomy, ligament length, skin elasticity, and post-operative traction adherence.

Erect gains are a different and far less flattering story. Erect length increases are minimal, typically 0.5 to 2 cm at best, and they are largely contingent on strict adherence to penile traction therapy for three to six months, and in some protocols up to a full year. Without diligent traction, erect gains are effectively negligible.

There is also a permanent change in erection angle. After ligamentolysis, the penis points downward during erection rather than upward or forward. This is not a temporary side effect. It is a permanent anatomical consequence that can cause difficulty during intercourse and partner dissatisfaction.

Finally, there is a paradox baked into the healing process. Post-surgical fibrosis can cause the ligament to reattach in a shortened position, potentially reversing all gains or even reducing baseline length below the pre-operative measurement. This risk is almost never mentioned in promotional material.

The Documented Risks: What Informed Consent Should Include

The following is the information a patient should receive before signing a consent form, not discover afterward. In rough order of clinical significance:

1. Permanent downward erection angle change, altering the mechanics of intercourse.
2. Penile instability and hypermobility during erection, which can cause the shaft to slip or buckle during penetration.
3. De novo erectile dysfunction, reported in roughly 3 to 5 percent of cases.
4. Damage to the dorsal neurovascular bundle, potentially affecting sensation.
5. Infection.
6. Scarring leading to paradoxical shortening via ligament reattachment.

The 2024 micro-anatomical research stated its conclusion bluntly: the findings “do not support an anatomical rationale for penile elongation surgery, without risking instability.” That is a direct challenge to the procedure’s foundational premise.

A landmark European Urology analysis concluded that these procedures “lack standardization,” have “poorly defined” outcome measures, carry “unacceptably high” complication rates, and should be regarded as “investigational.” The Sexual Medicine Society of North America’s 2024 position statement noted that these treatments “have not been recommended by mainstream sexual medicine societies,” largely due to a lack of published data.

These are not fringe warnings from skeptics. They are the formal positions of the European Association of Urology and the Sexual Medicine Society of North America.

What the Satisfaction Data Actually Shows

Satisfaction figures for ligamentolysis diverge sharply, and understanding why is essential.

The optimistic number, the one most surgical clinics lead with, comes from peer-reviewed case series reporting 82 to 88 percent patient satisfaction. The competing number, which most surgical content buries or omits, is roughly 35 percent satisfaction, meaning a 65 percent dissatisfaction rate.

What explains a gap that large? A 2025 review in the Journal of Sexual Medicine (Liu et al., Monash University/Alfred Hospital) flagged the methodological culprit directly: the higher satisfaction rates were confounded by the inclusion of patients with penile dysmorphic disorder (PDD) and Peyronie’s disease, populations with distinct psychological profiles and different baseline expectations.

Penile dysmorphic disorder is a recognized psychiatric condition, a subtype of body dysmorphic disorder, in which the size or shape of the penis becomes the primary preoccupation, causing significant shame or functional impairment. Research is clear that cosmetic surgery for men with genital dysmorphia, performed without prior psychological assessment and treatment, is “unlikely to be helpful” and may worsen outcomes.

The European Association of Urology’s 2023 guidelines are explicit: patients with normal penile size seeking augmentation should be referred for psychological evaluation for potential dysmorphophobic disorders before any surgical intervention is considered. The uncomfortable fact underneath all of it is this: most men seeking enhancement have clinically normal-sized penises. The SMSNA acknowledges that general curiosity about size can escalate into “full-on obsession and anxiety” that is “often unnecessary.”

The takeaway is that satisfaction is not determined by surgical technique alone. The psychological profile of the patient is the single strongest predictor of outcome, and surgical marketing ignores this almost entirely. For men trying to understand what constitutes average penile size based on clinical measurements, objective data is a more reliable starting point than marketing claims.

The Post-Operative Burden: What Providers Rarely Disclose Upfront

The fine print of ligamentolysis is where the promised results are either preserved or lost.

Traction is mandatory. Patients must use penile traction devices for several hours daily, commonly six to eight hours, for three to six months, with some protocols extending to a full year. This is not an optional add-on. It is the mechanism by which any erect length gain is achieved and held.

Non-compliance erases gains. Failure to adhere to the traction protocol risks losing everything the surgery accomplished, as the ligament reattaches during healing.

Activity is restricted. Sexual activity must be avoided for at least four to six weeks. Strenuous exercise is off the table for six weeks. Full recovery and final results take three to six months.

The cost is significant and out of pocket. The procedure is elective and not covered by insurance. US costs range from $10,000 to $25,000 for the surgery alone, before accounting for traction devices, potential revision surgery, lost wages during recovery, or the cost of managing complications.

For a professional in a demanding role, the honest calculation includes time, money, and logistics. Ligamentolysis is not a one-appointment solution. It is a multi-month commitment with real lifestyle disruption, and the traction burden alone is a leading reason many men who undergo the surgery never achieve the results they were shown in the consultation room.

Why the Medical Consensus Matters, and Why It Is Missing From Most Content

The formal positions of the governing bodies speak for themselves.

• EAU 2023 Guidelines: mandatory psychological evaluation before surgery for men with normal penile size.
• SMSNA 2024 Position Statement: historically not recommended by mainstream sexual medicine societies due to a lack of published data; calls for transparent counseling and patient safety as primary considerations.
• European Urology analysis: procedures are “investigational,” lack standardization, and carry unacceptably high complication rates.
• 2024 Medicina systematic review (46 studies): risks and complexities must be carefully accounted for, and thorough psychological and medical assessment is essential before surgery.
• BJU International systematic review: overall study quality is low, and standardized criteria for evaluating efficacy, safety, and patient satisfaction are missing.

Why is this consensus absent from commercial content? Because surgical clinics have a financial incentive to present the procedure favorably, and no regulatory body requires them to disclose institutional positions in their marketing. The absence is structural, not accidental. Male enhancement procedure transparency is a standard that patients should demand before committing to any intervention.

The Evidence-Aligned Alternative: Girth Enhancement Without Surgical Trade-Offs

The critical question for any man considering enhancement is what he is actually trying to change. Ligamentolysis addresses flaccid length, with substantial trade-offs. Research suggests that for most men, the more common concern is erect girth and appearance, which is an entirely different problem with an entirely different solution.

Girth and erect appearance can be addressed without touching the suspensory ligament, without altering erection angle, and without disturbing neurovascular function. That is the domain of non-surgical penile girth enhancement using injectable dermal filler, sometimes called filler phalloplasty.

For men whose specific goal is length rather than girth, there is also non-surgical evidence to consider. A 2025 narrative review in Cureus/PMC, covering 15 major studies and more than 1,000 patients, found that modern penile traction devices achieved length gains of 1.5 to 2.3 cm, with adherence exceeding 85 percent and minimal adverse effects. Those gains are comparable to surgical outcomes, without the surgical risk.

The core point is this: for the man whose dissatisfaction is primarily about girth and erect appearance, the surgical risk profile of ligamentolysis is simply not justified by the evidence.

Non-Surgical Girth Enhancement at Stoller Medical Group: What the Procedure Involves

At Stoller Medical Group, girth enhancement is performed using Belefil®, a hyaluronic acid-based, biocompatible, medical-grade dermal filler placed beneath the penile skin to enhance girth and volume. There is no cutting, no general anesthesia, and no alteration of internal anatomy.

• Procedure time: completed in under one hour as an outpatient treatment.
• Results: immediate visible enhancement, with 80 to 90 percent permanent improvement in girth and volume. Results look and feel natural in both flaccid and erect states, and normal sensation and function are preserved.
• Recovery: back to normal activity within 10 days, with sexual activity resuming within 7 to 10 days, compared to the four to six week minimum for surgical recovery.
• Longevity: results typically last 18 to 24 months, with optional periodic touch-up sessions.

The practice uses a staged, incremental protocol rather than dramatic single-session changes, prioritizing proportion, balance, and natural aesthetics. With more than 15,000 procedures performed across five locations in Manhattan, Long Island, Albany, Pennsylvania, and Minnesota, the clinical experience in this specialized field is substantial.

The practice’s decision not to offer surgical lengthening is a deliberate clinical and ethical choice, not a gap in capability.

Understanding the Investment: Pricing and What to Expect

In keeping with the honesty that runs throughout this article, the cost structure is transparent. Non-surgical girth enhancement pricing starts at $7,500 and increases depending on the patient’s desired results and the volume of filler required.

Pricing is structured by syringe. Most men begin with a minimum of 10 syringes, and the average first procedure involves approximately 15 syringes.

Compare that to the total cost of ligamentolysis: $10,000 to $25,000 for the surgery alone, plus traction devices, possible revision procedures, lost wages during a four to six week recovery, and the cost of managing any complications. When the full picture is considered honestly, the non-surgical option is financially competitive, with a fraction of the recovery burden and none of the permanent anatomical trade-offs.

Free consultations are available at all five locations. The consultation includes realistic goal-setting and a transparent discussion of outcomes, not a sales pitch.

Who Is, and Is Not, a Candidate for Each Approach

This is a clinical decision guide, not a sales filter.

Men who may be appropriate for a ligamentolysis consultation (with full informed consent) are those with a specific, documented concern about flaccid length who have been cleared by psychological evaluation, understand that the erection angle change is permanent, are prepared for six to twelve months of traction compliance, and hold realistic expectations about minimal erect gains.

Men for whom non-surgical girth enhancement is the evidence-aligned choice are those whose primary concern is erect girth and appearance, who value preserving erection angle and penile stability, who cannot accommodate four to six weeks of surgical recovery, and who prefer a reversible penis enlargement option. Understanding penile girth enhancement candidacy criteria is an important first step in that evaluation.

Men who should seek psychological evaluation before either procedure are those whose dissatisfaction is severe, pervasive, or disproportionate to objective measurements, consistent with penile dysmorphic disorder. Both the EAU guidelines and the psychiatric literature agree that surgery is unlikely to resolve underlying dysmorphic anxiety.

The right procedure is determined by an accurate diagnosis of what the patient actually needs, not by which procedure a clinic happens to offer.

Conclusion: Clinical Transparency Is the Standard, Not the Exception

Ligamentolysis produces apparent flaccid lengthening, not anatomical growth, while permanently altering erection angle and penile stability. These are not footnotes. They are the central facts of the procedure.

For some men, with complete information and appropriate psychological screening, ligamentolysis may still be a considered and legitimate choice. The purpose here is not to condemn the surgery but to ensure the decision is genuinely informed. The medical consensus is unambiguous: the EAU, the SMSNA, and European Urology all flag these procedures as investigational, under-studied, and requiring psychological evaluation before proceeding.

For men whose primary concern is girth and erect appearance, Stoller Medical Group offers a clinical alternative: more than 15,000 procedures performed, no surgical trade-offs, a 10-day recovery, and a practice that chose not to offer the surgery precisely because the evidence did not support it. The most confident decision a man can make is one built on complete information, and complete information is exactly what this practice is designed to provide.

Take the Next Step: Schedule a Free Consultation

A free consultation is available at any of the five locations: Manhattan (515 Madison Avenue), Long Island (Jericho), Albany (Latham), Pennsylvania (Chadds Ford), or Minnesota (Eagan).

The purpose of the consultation is not to sell a procedure. It is to assess individual anatomy, discuss realistic goals, and determine whether non-surgical girth enhancement is the right fit, or whether another pathway makes more sense. Discretion and confidentiality are core practice values.

The work is led by Dr. Roy B. Stoller, a board-certified physician with more than 25 years in aesthetic and restorative medicine and five years dedicated specifically to non-surgical male enhancement, supported by more than 15,000 procedures performed.

For financial context heading into that conversation: pricing starts at $7,500, with most men beginning at a minimum of 10 syringes and averaging 15 syringes during a first procedure.

The consultation is the beginning of an honest conversation, the kind this article was written to model.